DNA test for endometrial cancer using vaginal fluid
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether DNA markers in vaginal fluid can help detect endometrial cancer. You'll provide a sample and take part in a virtual interview.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Black individual aged 45 or older
- You were assigned female at birth
- You still have your uterus (no hysterectomy)
- You have had abnormal vaginal bleeding or spotting after menopause
- You can take part in a 45-minute virtual interview
- You have never been diagnosed with endometrial cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
This trial tests whether DNA changes in urine, vaginal, or cervical samples can help find endometrial cancer earlier in women with postmenopausal bleeding. If you are having tests for this bleeding, your samples could help improve detection.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study tests a simple cervical swab (like a Pap smear) to see if it can help find or monitor endometrial cancer or precancerous changes. It aims to find a less invasive way to screen and follow up on this condition.
This study collects vaginal fluid samples to test whether certain biological markers (substances in the fluid) can help detect gynecological cancers earlier or track how they change during treatment. You may qualify if you're being evaluated for, currently receiving treatment for, or receiving comfort care for a gynecological cancer.
Hear when a new Endometrial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.